From a therapeutic standpoint in renal cell carcinoma, inactivation of BAP1 sensitizes tumor cells to irradiation and PARP-inhibitors, which might be due to the impaired ability of double-stranded DNA breaks (87). The gene discussed is BAP1; the disease is hereditary clear cell renal cell carcinoma.